+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Carrier Screening Market By Technology, By End user, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

  • PDF Icon

    Report

  • 82 Pages
  • November 2021
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5514509

The Asia Pacific Carrier Screening Market is expected to witness market growth of 12.58% CAGR during the forecast period (2021-2027).

The chances to cure and effectively manage a disease is expected to grow manifold if it is diagnosed early. Treatment of the disease early may help the patient to accommodate it in a better way. Early disease detection assists individuals plan ahead, while they are still able to take valuable decisions in terms of their health and bolsters requirements and on financial and legal matters. Genetic disorders like sickle cell anemia, cystic fibrosis, and Tay-Sachs disease, are inherited disorders that are deadly in nature. However, carrier screening for these fatal diseases can offer valuable data regarding a couple’s possibility of having a child with a genetic disorder.

There is a growing demand for different diagnosis methods like carrier screening in developing countries like India, Japan, and China. This surging demand for wearables is expected to bolster the growth of the regional carrier screening market in the upcoming years. In addition, the rising cases of people suffering from different diseases will also positively impact the growth of the market in this region.

The Asia Pacific is witnessing high consumer awareness regarding their health and a surge in the number of chronic diseases. This is expected to act as a major catalyst for the growth of the regional carrier screening market. Moreover, players operating in this region are constantly developing different kinds of products to explore the genetic errors in the human body that is expected to help the people to prevent the chances of transmission of the defected genes to their offspring. These factors are expected to open new growth avenues for the players operating in the regional carrier screening market during the forecasting period.

The China market dominated the Asia Pacific Carrier Screening Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $158.2 million by 2027. The Japan market is poised to grow a CAGR of 13.9% during (2021 - 2027). Additionally, The India market is anticipated to grow a CAGR of 14% during (2021 - 2027).

Based on Technology, the market is segmented into DNA Sequencing, Microarrays, Polymerase Chain Reaction and Other technology. Based on End user, the market is segmented into Hospital and Clinics, Physician Offices, Reference Laboratories and Other End Users. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.



The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics, Incorporated, Thermo Fisher Scientific, Illumina, Inc., Eurofins Scientific Group, Invitae Corporation, OPKO Health, Inc., Fulgent Genetics, Sema4 OpCo, Inc., Myriad Genetics, Inc., and Natera, Inc.



Scope of the Study

Market Segments Covered in the Report:


By Type


  • Expanded Carrier Screening and
  • Targeted Disease Carrier Screening

By Technology


  • DNA Sequencing
  • Microarrays
  • Polymerase Chain Reaction and
  • Other technology

By End User


  • Hospital and Clinics
  • Physician Offices
  • Reference Laboratories and
  • Other End Users

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:


  • Quest Diagnostics, Incorporated
  • Thermo Fisher Scientific
  • Illumina, Inc.
  • Eurofins Scientific Group
  • Invitae Corporation
  • OPKO Health, Inc.
  • Fulgent Genetics
  • Sema4 OpCo, Inc.
  • Myriad Genetics, Inc.
  • Natera, Inc.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Carrier Screening Market, by Type
1.4.2 Asia Pacific Carrier Screening Market, by Technology
1.4.3 Asia Pacific Carrier Screening Market, by End User
1.4.4 Asia Pacific Carrier Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2017, Jun - 2021, Jun) Leading Players
Chapter 4. Asia Pacific Carrier Screening Market by Type
4.1 Asia Pacific Expanded Carrier Screening Market by Country
4.2 Asia Pacific Targeted Disease Carrier Screening Market by Country
Chapter 5. Asia Pacific Carrier Screening Market by Technology
5.1 Asia Pacific DNA Sequencing Market by Country
5.2 Asia Pacific Microarrays Market by Country
5.3 Asia Pacific Polymerase Chain Reaction Market by Country
5.4 Asia Pacific Other Technologies Market by Country
Chapter 6. Asia Pacific Carrier Screening Market by End user
6.1 Asia Pacific Hospital and Clinics Market by Country
6.2 Asia Pacific Physician Offices Market by Country
6.3 Asia Pacific Reference Laboratories Market by Country
6.4 Asia Pacific Other End user Market by Country
Chapter 7. Asia Pacific Carrier Screening Market by Country
7.1 China Carrier Screening Market
7.1.1 China Carrier Screening Market by Type
7.1.2 China Carrier Screening Market by Technology
7.1.3 China Carrier Screening Market by End user
7.2 Japan Carrier Screening Market
7.2.1 Japan Carrier Screening Market by Type
7.2.2 Japan Carrier Screening Market by Technology
7.2.3 Japan Carrier Screening Market by End user
7.3 India Carrier Screening Market
7.3.1 India Carrier Screening Market by Type
7.3.2 India Carrier Screening Market by Technology
7.3.3 India Carrier Screening Market by End user
7.4 South Korea Carrier Screening Market
7.4.1 South Korea Carrier Screening Market by Type
7.4.2 South Korea Carrier Screening Market by Technology
7.4.3 South Korea Carrier Screening Market by End user
7.5 Singapore Carrier Screening Market
7.5.1 Singapore Carrier Screening Market by Type
7.5.2 Singapore Carrier Screening Market by Technology
7.5.3 Singapore Carrier Screening Market by End user
7.6 Malaysia Carrier Screening Market
7.6.1 Malaysia Carrier Screening Market by Type
7.6.2 Malaysia Carrier Screening Market by Technology
7.6.3 Malaysia Carrier Screening Market by End user
7.7 Rest of Asia Pacific Carrier Screening Market
7.7.1 Rest of Asia Pacific Carrier Screening Market by Type
7.7.2 Rest of Asia Pacific Carrier Screening Market by Technology
7.7.3 Rest of Asia Pacific Carrier Screening Market by End user
Chapter 8. Company Profiles
8.1 Quest Diagnostics, Incorporated
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Recent strategies and developments:
8.1.2.1 Partnerships, Collaborations, and Agreements:
8.1.2.2 Product Launches and Product Expansions:
8.1.2.3 Acquisition and Mergers:
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 Illumina, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Eurofins Scientific Group
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Partnerships, Collaborations, and Agreements:
8.4.4.2 Acquisition and Mergers:
8.5 Invitae Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.5.2 Acquisition and Mergers:
8.6 OPKO Health, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.7 Fulgent Genetics
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Sema4 OpCo, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.9 Myriad Genetics, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.5.2 Product Launches and Product Expansions:
8.1 Natera Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:

Companies Mentioned

  • Quest Diagnostics, Incorporated
  • Thermo Fisher Scientific
  • Illumina, Inc.
  • Eurofins Scientific Group
  • Invitae Corporation
  • OPKO Health, Inc.
  • Fulgent Genetics
  • Sema4 OpCo, Inc.
  • Myriad Genetics, Inc.
  • Natera, Inc.

Methodology

Loading
LOADING...